The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study (2023)
- Authors:
- Autor USP: HONORIO, KÁTHIA MARIA - EACH
- Unidade: EACH
- DOI: 10.3389/fddsv.2023.1237655
- Assunto: INIBIÇÃO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Drug Discovery
- ISSN: 2214-6210
- Volume/Número/Paginação/Ano: v. 3, p. 01-18, July 2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SERAFIM, Mateus Sá Magalhães et al. The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study. Frontiers in Drug Discovery, v. 3, p. 01-18, 2023Tradução . . Disponível em: https://doi.org/10.3389/fddsv.2023.1237655. Acesso em: 03 mar. 2026. -
APA
Serafim, M. S. M., Pantaleão, S. Q., Silva, E. B. da, McKerrow, J. H., O\2019Donoghue, A. J., Mota, B. E. F., et al. (2023). The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study. Frontiers in Drug Discovery, 3, 01-18. doi:10.3389/fddsv.2023.1237655 -
NLM
Serafim MSM, Pantaleão SQ, Silva EB da, McKerrow JH, O\2019Donoghue AJ, Mota BEF, Honorio KM, Maltarollo VG. The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study [Internet]. Frontiers in Drug Discovery. 2023 ; 3 01-18.[citado 2026 mar. 03 ] Available from: https://doi.org/10.3389/fddsv.2023.1237655 -
Vancouver
Serafim MSM, Pantaleão SQ, Silva EB da, McKerrow JH, O\2019Donoghue AJ, Mota BEF, Honorio KM, Maltarollo VG. The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study [Internet]. Frontiers in Drug Discovery. 2023 ; 3 01-18.[citado 2026 mar. 03 ] Available from: https://doi.org/10.3389/fddsv.2023.1237655 - Virtual screening and in vitro assays of novel hits as promising DPP-4 inhibitors
- MASSA Algorithm: automated rational sampling of training and test subsets for QSAR modelling
- Recent advances in the prediction of pharmacokinetics properties in drug design studies: a review
- Machine learning techniques applied to the drug design and discovery of new antivirals: a brief look over the past decade
- The potential of secondary metabolites from plants as drugs or leads against trypanosoma cruzi-An Update from 2012 to 2021
- Andrographolide: a diterpenoid from cymbopogon schoenanthus identified as a new hit compound against trypanosoma cruzi using machine learning and experimental approaches
- Design of Inhibitors for Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Enzyme of Leishmania mexicana
- Semisynthetic p-coumaric acid derivatives as leadDual inhibitors against DPP-IV and GSK-3β for antidiabetic therapy
- Machine learning models for the identification of natural products with anti-schistosomiasis activity
- Study of the CuII Affinity by Three Chelating Agents of Biological Interest: TPEN, TRIEN and Et2DTC
Informações sobre o DOI: 10.3389/fddsv.2023.1237655 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
